<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://pharmoniq.com/news/bms-zenbexus-fda-accelerated-approval-multiple-myeloma</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-18T08:47:02.884Z</news:publication_date>
      <news:title>FDA Grants Accelerated Approval to Bristol Myers Squibb&apos;s Zenbexus</news:title>
      <news:keywords>Bristol Myers Squibb, FDA approval, multiple myeloma, oncology, Zenbexus</news:keywords>
    </news:news>
  </url>
  <url>
    <loc>https://pharmoniq.com/news/fda-approves-centanafadine-simtriyo-triple-reuptake-inhibitor-adhd</loc>
    <news:news>
      <news:publication>
        <news:name>PharmoniQ</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-17T14:10:49.833Z</news:publication_date>
      <news:title>FDA Approves Centanafadine as First Triple Reuptake Inhibitor for ADHD</news:title>
      <news:keywords>ADHD, FDA approval, centanafadine, neurotransmitters, psychiatric medications</news:keywords>
    </news:news>
  </url>
</urlset>